Skip to content

Clinical trials

Terminated Myeloproliferative Disorders trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myeloproliferative Disorders Status: Terminated Country / region: United States Clear all

82 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20021
20032
20045
20052
20066
20077
20087
20094
20108
20111
20123
20131
20142
20154
20163
20173
20181
20193
20203
20214
20223
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated82

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Incyte Corporation9
OHSU Knight Cancer Institute6
Baylor College of Medicine4
City of Hope Medical Center4
Vanderbilt-Ingram Cancer Center4
CTI BioPharma3
Mayo Clinic3
National Cancer Institute (NCI)3
Alliance for Clinical Trials in Oncology2
H. Lee Moffitt Cancer Center and Research Institute2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myeloproliferative Disorders82
Primary Myelofibrosis46
Myelodysplastic Syndromes42
Leukemia, Myeloid, Acute39
Multiple Myeloma39
Leukemia35
Lymphoma, Non-Hodgkin33
Leukemia, Lymphocytic, Chronic, B-Cell32
Leukemia, Myelomonocytic, Chronic32
Precursor Cell Lymphoblastic Leukemia-Lymphoma32

Trials

Showing 1 to 25 of 82. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.